<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(11)</volume><submitter>Quesada S</submitter><journal>Annals of translational medicine</journal><pagination>393</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10632578</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The quest for the optimal biomarker: is extending the spectrum of targeted &lt;i>PIK3CA&lt;/i> mutations in breast cancer carcinoma worthwhile?</pubmed_title><pmcid>PMC10632578</pmcid><pubmed_authors>Jacot W</pubmed_authors><pubmed_authors>Quesada S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The quest for the optimal biomarker: is extending the spectrum of targeted &lt;i>PIK3CA&lt;/i> mutations in breast cancer carcinoma worthwhile?</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-28T14:50:17.657Z</modification><creation>2025-04-04T11:02:18.485Z</creation></dates><accession>S-EPMC10632578</accession><cross_references><pubmed>37970606</pubmed><doi>10.21037/atm-23-1608</doi></cross_references></HashMap>